ARTHRITIC PSORIASIS

Clinical trials for ARTHRITIC PSORIASIS explained in plain language.

Never miss a new study

Get alerted when new ARTHRITIC PSORIASIS trials appear

Sign up with your email to follow new studies for ARTHRITIC PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New daily pill aims to tame psoriatic arthritis symptoms

Disease control Not yet recruiting

This phase 2 trial tests an experimental oral drug called CBP-0276 in adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin plaques. Participants receive either a low dose (200 mg), a high dose (800 mg), or a placebo daily for 24 weeks. The ma…

Matched conditions: ARTHRITIC PSORIASIS

Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

ARTHRITIC PSORIASIS

Get alerted when new ARTHRITIC PSORIASIS trials appear

New daily pill aims to tame psoriatic arthritis symptoms